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Parkinson’s disease (PD) is the second most common
neurodegenerative disorder, characterized pathologically by
loss of dopaminergic neurons in the substantia nigra pars
compacta. The etiology of PD is still unknown, involving
genetic and environmental factors; however mitochondrial
dysfunction plays a central role in PD pathogenesis. In this
regard, several PD-related proteins (PINK1, Parkin, DJ-1,
LRRK2, and 𝛼-synuclein) are linked to mitochondrial func-
tion. Mitochondria are highly dynamic organelles involved
in essential cellular functions, including energy production,
calcium homeostasis, metabolism of amino acids and lipids,
mtDNA replication, and programmed cell death. Moreover,
mitochondrial homeostasis is tightly regulated by several
pathways, including mitochondrial biogenesis, remodeling
(fusion/fission), and clearance of damaged mitochondria
by autophagy (mitophagy), among others. Mitochondrial
dysfunction and the engagement of calcium channels dur-
ing autonomous pacemaking have been implicated in the
increased susceptibility of dopaminergic neurons to cell
death in the substantia nigra.
This special issue is comprised of two reviews and five
articles, which provide new insights into the molecular and
cellular pathways related to mitochondria that may influence
the pathogenesis of PD.
In the first review (“Chaperone-Mediated Autophagy
andMitochondrial Homeostasis in Parkinson’s Disease”), the
authors summarize the current knowledge about autophagy
and the relevance of this degradative pathway in the mainte-
nance of mitochondrial function. Specifically, they highlight
the link betweenmitochondrial dysfunction and impairment
of chaperone-mediated autophagy activity in PD patients.
The second review, titled “Parkinson’s Disease: The
Mitochondria-Iron Link,” is focused on the relationship
between accumulation of redox-active iron and the develop-
ment/pathogenesis of PD. It is well-known thatmitochondria
are involved in the exchange of iron with the cytoplasm,
with evidence suggesting that dysfunction in PD-related
proteins (i.e., 𝛼-synuclein, Parkin, PINK1, DJ-1, LRRK2,
and ATP13A2) leads to iron dysregulation. Because of the
neurotoxicity linked to iron accumulation, Y. Mun˜oz et al.
suggest that iron chelation is a potential therapeutic approach
to slow down the progression of the disease.
Related to the previous review, the first research paper
included in this special issue, entitled “Protection against
Mitochondrial and Metal Toxicity Depends on Functional
Lipid Binding Sites inATP13A2,” examines the cytoprotective
role of ATP132A and its consideration as a therapeutic target
to reduce cellular toxicity. S. Martin et al. demonstrate that
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ATP132A requires the signaling lipids phosphatidic acid and
phosphatidylinositol 3,5-bisphosphate to mediate protection
to toxic Mn2+/Zn2+/Fe3+ concentrations and mitochondrial
stress by the toxins rotenone and MPP+.
In the second research article, “Methyl-Arginine Profile
of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests
Altered Mitochondrial Biogenesis,” G. Auburger et al. use a
powerful experimental model (PINK1-knockout with over-
expression of A53T-SNCA double-mutant mice) to elucidate
the polygenic etiology of PD. Based on quantitative global
proteomics focused on methyl-arginine modifications, they
report upregulation and downregulation of this specific post-
translationalmodification in several proteins, including some
related to mitochondrial biogenesis such as CRTC1 and PSF.
Moreover, posttranslational alterations of other identified
factors could be required in molecular events linked to PD
or other neurodegenerative disorders.
The third research article, “Altered Mitochondrial Res-
piration and Other Features of Mitochondrial Function
in Parkin-Mutant Fibroblasts from Parkinson’s Disease
Patients” by W. Haylett et al., investigates mitochondrial
health in Parkin-mutant fibroblasts from PD patients. Their
results show that mitochondrial respiration and cell growth
are higher in these cells, suggesting a compensatory mecha-
nism in the absence of Parkin. Identification of this response
could be a therapeutic target to preserve mitochondrial
function in PD patients with Parkin mutations.
The fourth research paper of this special issue, “A
Feed-Forward Circuit of Endogenous PGC-1𝛼 and Estrogen
Related Receptor 𝛼 Regulates the Neuronal Electron Trans-
port Chain,” addresses the role of the key mitochondrial
regulator PGC-1𝛼 in the activation of the nuclear-encoded
mitochondrial electron transport chain (ETC) genes. R.
Bakshi et al. show that PGC-1𝛼 regulates ERR𝛼 transcrip-
tion. Interestingly, they report that pioglitazone treatment
increases expression of endogenous PGC-1𝛼, ERR𝛼, and their
ETC target genes. The modulation of the PGC-1𝛼 transcrip-
tion network by drug administration could potentially be a
clinical target for PD and other neurodegenerative diseases.
In the final review, “ActivationMechanism of LRRK2 and
Its Cellular Functions in Parkinson’s Disease,” the authors
discuss the cellular role of LRRK2 and the recent research
linking LRRK2-mediated PD to mitochondrial dysfunction
and aberrant autophagy. In this regard, PD-associated muta-
tions in LRRK2 lead to impaired kinase and decreased
GTPase activity. Thus, development of kinase inhibitors,
as well as characterization of substrates and regulators of
LRRK2, is essential in understanding LRRK2 pathogenesis
and identifying potential targets for therapy.
The main purpose of this special issue is to shed light
on the relevance of mitochondria as an essential organelle
in postmitotic cells such as neurons and how mitochondrial
damage contributes to the PD pathogenesis. An accurate and
comprehensive understanding of mitochondrial quality con-
trol processes is critical to prevent cell death and development
of age-related neurodegenerative disorders like PD. Current
therapeutic strategies in PD are based on slowing down
disease progression; however, they are not successful. New
therapeutic approaches should be based on early biomarkers
of PD andmitochondrial dysfunction is one promising target
to be investigated.
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